{
    "ticker": "BSJQ",
    "name": "BioSig Technologies, Inc.",
    "description": "BioSig Technologies, Inc. is a medical technology company focused on improving the accuracy of electrophysiology procedures for cardiac arrhythmias. Founded in 2012, BioSig is driven by the mission to enhance the precision of cardiac procedures through its proprietary technology platform, which integrates advanced signal processing with a unique digital signal acquisition system. The company\u2019s flagship product, the PURE EP System, is designed to provide electrophysiologists with clearer and more reliable data during cardiac procedures, which can lead to better outcomes for patients. The PURE EP System has been developed to address the challenges of current electrophysiology mapping systems, offering enhanced visualization of cardiac signals, thereby assisting clinicians in making more informed decisions. BioSig is committed to advancing healthcare through innovative solutions that enhance procedural efficiency and patient safety. With a growing portfolio of intellectual property and a focus on clinical validation, BioSig aims to be at the forefront of the electrophysiology market, addressing an urgent need for improved diagnostic and therapeutic tools in the treatment of heart rhythm disorders.",
    "industry": [
        "Medical Technology",
        "Healthcare"
    ],
    "headquarters": "Los Angeles, California, USA",
    "founded": "2012",
    "website": "https://www.biosig.com",
    "ceo": "W. Scott McLeod",
    "social_media": {
        "twitter": "https://twitter.com/BioSigTech",
        "linkedin": "https://www.linkedin.com/company/biosig-technologies-inc/"
    },
    "investor_relations": "https://www.biosig.com/investors/",
    "key_executives": [
        {
            "name": "W. Scott McLeod",
            "position": "CEO"
        },
        {
            "name": "David L. Smith",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Electrophysiology Devices",
            "products": [
                "PURE EP System"
            ]
        }
    ],
    "seo": {
        "meta_title": "BioSig Technologies, Inc. | Advancing Electrophysiology Solutions",
        "meta_description": "Explore BioSig Technologies, Inc., a leader in medical technology focused on improving the accuracy of cardiac procedures. Learn about their innovative PURE EP System.",
        "keywords": [
            "BioSig Technologies",
            "Electrophysiology",
            "Cardiac Arrhythmias",
            "Healthcare Technology",
            "PURE EP System"
        ]
    },
    "faq": [
        {
            "question": "What is BioSig Technologies known for?",
            "answer": "BioSig Technologies is known for its innovative medical technology solutions aimed at improving electrophysiology procedures."
        },
        {
            "question": "Who is the CEO of BioSig Technologies?",
            "answer": "W. Scott McLeod is the CEO of BioSig Technologies, Inc."
        },
        {
            "question": "Where is BioSig Technologies headquartered?",
            "answer": "BioSig Technologies is headquartered in Los Angeles, California, USA."
        },
        {
            "question": "What is BioSig's main product?",
            "answer": "BioSig's main product is the PURE EP System, designed for electrophysiology procedures."
        },
        {
            "question": "When was BioSig Technologies founded?",
            "answer": "BioSig Technologies was founded in 2012."
        }
    ],
    "competitors": [
        "MDT",
        "ABT",
        "CRY"
    ],
    "related_stocks": [
        "JNJ",
        "ISRG",
        "SYK",
        "BDX"
    ]
}